Company: REVB
Filing Date: 2025-12-03
Form Type: 8-K
Source: 0001193125-25-306915
Chunk: 2

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-12-03
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Information.

At the conclusion of the meeting, James Rolke, the Company’s CEO, provided a brief corporate update regarding recent progress and product developments. A copy of the transcript of the corporate update is furnished as Exhibit 99.1 to this Current Report on Form 8‑ K and is incorporated herein by reference.

The information in this Item 8.01 and in Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.